Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Extrapolation of Efficacy in Pediatric Drug Development and Evidence-based Medicine: Progress and Lessons Learned.

Sun H, Temeck JW, Chambers W, Perkins G, Bonnel R, Murphy D.

Ther Innov Regul Sci. 2017;2017:1-7. doi: 10.1177/2168479017725558. Epub 2017 Aug 18.

2.

Approaches to the development and marketing approval of drugs that prevent cancer.

Kelloff GJ, Johnson JR, Crowell JA, Boone CW, DeGeorge JJ, Steele VE, Mehta MU, Temeck JW, Schmidt WJ, Burke G, et al.

Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb;4(1):1-10. Review.

3.

Guidance for development of chemopreventive agents.

Kelloff GJ, Johnson JR, Crowell JA, Boone CW, DeGeorge JJ, Steele VE, Mehta MU, Temeck JW, Schmidt WJ, Burke G, et al.

J Cell Biochem Suppl. 1994;20:25-31. No abstract available.

PMID:
7616748
4.

Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient.

New MI, Brown P, Temeck JW, Owens C, Hedley-Whyte ET, Richardson EP.

Neurology. 1988 Jul;38(7):1133-4.

PMID:
3290704
5.

Adrenal androgen response to metyrapone, adrenocorticotropin, and corticotropin-releasing hormone stimulation in children with hypopituitarism.

Pang SY, Legido A, Levine LS, Temeck JW, New MI.

J Clin Endocrinol Metab. 1987 Aug;65(2):282-9.

PMID:
3036902
6.

Genetic defects of steroidogenesis in premature pubarche.

Temeck JW, Pang SY, Nelson C, New MI.

J Clin Endocrinol Metab. 1987 Mar;64(3):609-17.

PMID:
3029158
7.

Serous otitis media. A double-blind trial with sulfisoxazole.

de Castro FJ, Jaeger RW, Martin L, Temeck JW, Tournour B.

Mo Med. 1982 Sep;79(9):629-30. No abstract available.

PMID:
6757712

Supplemental Content

Loading ...
Support Center